Skip to main content
Veterinary Medicines

Veracin RS

Authorised
  • Dihydrostreptomycin sulfate
  • Benzylpenicillin procaine monohydrate
  • Benzathine benzylpenicillin

Product identification

Medicine name:
Veracin RS
Active substance:
  • Dihydrostreptomycin sulfate
  • Benzylpenicillin procaine monohydrate
  • Benzathine benzylpenicillin
Target species:
  • Cattle (pre-ruminant)
  • Pig
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Dihydrostreptomycin sulfate
    258.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Benzylpenicillin procaine monohydrate
    120.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Benzathine benzylpenicillin
    76.19
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle (pre-ruminant)
      • Meat and offal
        110
        day
    • Pig
      • Meat and offal
        130
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01RA01
Authorisation status:
  • Valid
Authorised in:
  • Germany
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Dechra Veterinary Products Deutschland GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Dechra Veterinary Products Deutschland GmbH
Responsible authority:
  • Federal Office Of Consumer Protection And Food Safety
Authorisation number:
  • 6382616.00.00
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
German (RTF)
Published on: 6/02/2024
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."